New high-cost cardiovascular drugs.

When looked at as a unified market, cardiovascular disease (CVD) is a very large, heavily populated ecosystem, inhabited by large numbers of healthcare delivery systems, therapeutic drugs, medical devices and drug/device combinations, patient support systems